ASM’s COVID-19 Research Registry to Pause Postings
Washington, D.C. — The COVID-19 Research Registry (Registry) has been an exciting collaboration between ASM volunteer leaders, staff and members throughout the past 2.5 years. In April 2020, we saw an acute need within our scientific community for timely, vetted information about COVID-19, and we acted quickly to build this dynamic resource. Since the Registry launched, more than 2,500 articles have been published on it and more than 80,000 users have engaged with its content. These numbers are a testament to the success and impact of the Registry.As COVID-19 transitions from a pandemic to an endemic phase, we have completed our original intention to establish the COVID-19 Registry to provide reliable, up-to-date information about COVID-19 research. The web traffic to the Registry has decreased starting this summer, and engagement on asm.org has shifted to other topics. Therefore, we will pause the activities of the COVID-19 Registry by the end of October 2022. Although we will not continue to update the Registry, the Registry site and all the information will remain open for the community to access. ASM will continue to monitor the COVID-19 situation and will share and publish the most important information on asm.org and in . If the need arises in the future, ASM will resume the Registry activities.
As we envisioned and created the Registry, it was our aim to curate a collection of timely, impactful research. We hope that we’ve fulfilled this mission and provided you with the most significant COVID-19 research over the past 2.5 years. Throughout the lifespan of the Registry, we have published weekly COVID-19 research updates by the Curator-in-Chief Dr. Lynn Enquist and more than 50 biweekly commentaries by the curators. We are also proud to have hosted 16 monthly virtual journal clubs, which attracted a global audience of researchers and educators from more than 40 countries. Thank you for engaging with this project; it is members and participants like you who have made ASM’s COVID-19 Research Registry a success.
